Allam Venkata Sita Rama Raju, Sukkar Maria B
Graduate School of Health, Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Methods Mol Biol. 2020;2080:203-212. doi: 10.1007/978-1-4939-9936-1_18.
Experimental mouse models of asthma are widely used to investigate the underlying mechanisms of this complex and heterogeneous disease. Using mouse models of ovalbumin-induced asthma, previous investigators have established a crucial role for MIF in the development of type 2-mediated eosinophilic asthma. Surprisingly, however, the role of MIF in other phenotypes of asthma has received little attention. MIF is an important mediator of neutrophilic inflammation, and also acts to antagonize the actions of corticosteroids. Thus, MIF may play a role in the development of severe forms of asthma in which airway neutrophilia and corticosteroid insensitivity are major features. In this chapter, we provide an experimental protocol that may be used to investigate the role of MIF in a mouse model of severe corticosteroid-resistant neutrophilic asthma.
哮喘的实验小鼠模型被广泛用于研究这种复杂的异质性疾病的潜在机制。利用卵清蛋白诱导的哮喘小鼠模型,先前的研究人员已证实巨噬细胞移动抑制因子(MIF)在2型介导的嗜酸性粒细胞性哮喘发展中起关键作用。然而,令人惊讶的是,MIF在哮喘其他表型中的作用却很少受到关注。MIF是中性粒细胞炎症的重要介质,并且还能拮抗皮质类固醇的作用。因此,MIF可能在以气道中性粒细胞增多和皮质类固醇不敏感为主要特征的重度哮喘形式的发展中起作用。在本章中,我们提供了一个实验方案,可用于研究MIF在重度皮质类固醇抵抗性中性粒细胞性哮喘小鼠模型中的作用。